After a PhD in Developmental Biology from the Pasteur Institute and the University of Paris Sorbonne, he joined the TISSIUM team 6 years ago after spending 4 years in the pharmaceutical industry. Recruited as a Pre-Clinical Scientist, he moved up the ranks and is now Head of New Concepts S&A. His team is responsible for identifying and validating new therapeutic indications (such as Sealants and adhesives).
Freshly graduated from Sup'Biotech School, Elisa joined TISSIUM in 2017 in order to do her end of studies internship. These four years have allowed her to evolve through different positions each with their own requirements while being exposed to many exciting challenges.
Elisa is now in charge of thinking and establishing the pre-clinical strategy to evaluate new indications for TISSIUM polymers. She continues to develop her skills while cultivating her interest in the field of health and innovation within a dynamic and stimulating team with whom there is never a dull moment!
Maria Pereira leads the Innovation Hub at TISSIUM. She co-invented the technology while a PhD student at Prof. Jeff Karp’s Laboratories. She has been recognized for her research by MIT Tech Review’s “35 Innovators Under 35” in 2014, as well as Forbes in its “30 under 30” selection in Healthcare in 2015. Maria holds a PhD in Bioengineering from the MIT-Portugal program and an MBA from INSEAD.
Clara is a pharmacist and holds a Master's degree in Health Engineering. She has five years of experience in quality and regulatory affairs. She started her career as a consultant for medical device and pharmaceutical manufacturers.
After starting at TISSIUM as a consultant, Clara became Head of Regulatory Submissions within the company. Through a wide range of assignments, she interacts with regulatory authorities and all departments of the company to ensure compliance with regulatory requirements to provide safe and effective products to patients.
Emmanuel joined Tissium in 2017 after spending 15 years in R&D and production in the pharmaceutical industry. He first held the position of Polymer Manufacturing Manager to strengthen the chemistry expertise of the development department. He was responsible for the development of Tissium's polymer synthesis processes and participated in the deployment of Tissium's manufacturing site near Lille.
Emmanuel now leads the CMC (Chemistry, Manufacturing, Controls) team in charge of the industrialization and control of new polymers to ensure the safety and performance of the company's medical devices. When he is not juggling molecules or chasing his two daughters, Emmanuel loves to pick up his guitar and discuss music over a drink.
Founded in 2013, Tissium is a fast-moving medical device company dedicated to developing innovative tissue reconstruction solutions.
The company leverages its technology platforms to develop new innovative solutions in surgery for a positive impact on patients' lives. The company is headquartered in Paris, with a production facility in Roncq (near Lille) and an office in Boston.
Tissium's technology is based on research and intellectual property from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women's Hospital), who co-founded the company.
Tissium is developing surgical polymers for tissue repair during surgical procedures based on its proprietary, elastomeric, biodegradable, biocompatible polymers for in situ wound closure, in the presence of blood during surgery and tissue reconstruction.
The company's strategy is to develop a platform of innovations in the field of tissue reconstruction based on surgical polymers. These innovative devices, inspired by nature, will allow for less invasive surgery for the patient in areas such as Cardiovascular, Peripheral Nerve, Hernia and Digestive Surgery.
Tissium's mission is to bring a new era of body repair.
Tissium teams are driven by the conviction that their ability to innovate, their resilience and their ability to work as a team are fundamental to developing solutions that benefit patients' lives.
Joining Tissium means participating in a human adventure, in a stimulating and fast-growing environment, while helping to build a future leader in its field.
The team is composed of more than 13 different nationalities. Diversity is a strength at Tissium.
Tissium is part of the French Tech 120 startups for the second time in a row.
The offices are located in an emblematic building in the Bastille district.
The possibility of working from anywhere.
Transparency is one of their values, information is shared during regular staff meetings where all questions are welcome.